Now Is A Good Time To Buy Opko Health Inc (NASDAQ: OPK)

During the last session, Opko Health Inc (NASDAQ:OPK)’s traded shares were 6.06 million, with the beta value of the company hitting 1.81. At the end of the trading day, the stock’s price was $1.23, reflecting an intraday loss of -1.60% or -$0.02. The 52-week high for the OPK share is $2.24, that puts it down -82.11 from that peak though still a striking 30.89% gain since the share price plummeted to a 52-week low of $0.85. The company’s market capitalization is $857.30M, and the average trade volume was 9.20 million shares over the past three months.

Opko Health Inc (NASDAQ:OPK) trade information

Opko Health Inc (OPK) registered a -1.60% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.60% in intraday trading to $1.23, hitting a weekly high. The stock’s 5-day price performance is -1.60%, and it has moved by 21.78% in 30 days. Based on these gigs, the overall price performance for the year is -15.75%.

Opko Health Inc (OPK) estimates and forecasts

Statistics show that Opko Health Inc has underperformed its competitors in share price, compared to the industry in which it operates. Opko Health Inc (OPK) shares have gone down -2.38% during the last six months, with a year-to-date growth rate less than the industry average at -32.00% against 14.60. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -350.00% this quarter and then drop -200.00% in the quarter after that. In the rating firms’ projections, revenue will decrease -13.20% compared to the previous financial year.

Revenue for the current quarter is expected to be $182.99 million as predicted by 6 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to $187.04 million by the end of Jun 2024. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $237.6 million and $201.97 million respectively. In this case, analysts expect current quarter sales to shrink by -23.00% and then drop by -7.40% in the coming quarter.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 1.56%. While earnings are projected to return -46.29% in 2024, the next five years will return 12.00% per annum.

OPK Dividends

Opko Health Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Opko Health Inc (NASDAQ:OPK)’s Major holders